Annual Retained Earnings
-$148.92 M
+$673.73 M+81.90%
December 31, 2024
Summary
- As of March 12, 2025, AGIO annual retained earnings is -$148.92 million, with the most recent change of +$673.73 million (+81.90%) on December 31, 2024.
- During the last 3 years, AGIO annual retained earnings has risen by +$89.84 million (+37.63%).
- AGIO annual retained earnings is now -176.12% below its all-time high of -$53.94 million, reached on December 31, 2011.
Performance
AGIO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$148.92 M
-$96.52 M-184.20%
December 31, 2024
Summary
- As of March 12, 2025, AGIO quarterly retained earnings is -$148.92 million, with the most recent change of -$96.52 million (-184.20%) on December 31, 2024.
- Over the past year, AGIO quarterly retained earnings has increased by +$673.73 million (+81.90%).
- AGIO quarterly retained earnings is now -582.74% below its all-time high of $30.85 million, reached on March 31, 2021.
Performance
AGIO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AGIO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +81.9% | +81.9% |
| 3 y3 years | +37.6% | +81.9% |
| 5 y5 years | +90.2% | +81.9% |
AGIO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +81.9% | -184.2% | +85.1% |
| 5 y | 5-year | at high | +91.9% | -582.7% | +91.9% |
| alltime | all time | -176.1% | +91.9% | -582.7% | +91.9% |
Agios Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$148.92 M(-81.9%) | -$148.92 M(+184.2%) |
| Sep 2024 | - | -$52.40 M(-94.8%) |
| Jun 2024 | - | -$1.00 B(+10.6%) |
| Mar 2024 | - | -$904.20 M(+9.9%) |
| Dec 2023 | -$822.65 M(+74.8%) | -$822.65 M(+13.2%) |
| Sep 2023 | - | -$726.71 M(+14.4%) |
| Jun 2023 | - | -$635.38 M(+15.2%) |
| Mar 2023 | - | -$551.58 M(+17.2%) |
| Dec 2022 | -$470.56 M(+97.1%) | -$470.56 M(-7.2%) |
| Sep 2022 | - | -$507.09 M(+19.2%) |
| Jun 2022 | - | -$425.34 M(+27.5%) |
| Mar 2022 | - | -$333.53 M(+39.7%) |
| Dec 2021 | -$238.76 M(-87.0%) | -$238.76 M(+65.7%) |
| Sep 2021 | - | -$144.13 M(+160.3%) |
| Jun 2021 | - | -$55.37 M(-279.5%) |
| Mar 2021 | - | $30.85 M(-101.7%) |
| Dec 2020 | -$1.84 B(+21.6%) | -$1.84 B(+5.6%) |
| Sep 2020 | - | -$1.75 B(+6.0%) |
| Jun 2020 | - | -$1.65 B(+5.8%) |
| Mar 2020 | - | -$1.56 B(+2.7%) |
| Dec 2019 | -$1.52 B(+37.2%) | -$1.52 B(+7.2%) |
| Sep 2019 | - | -$1.41 B(+8.1%) |
| Jun 2019 | - | -$1.31 B(+9.2%) |
| Mar 2019 | - | -$1.20 B(+8.4%) |
| Dec 2018 | -$1.10 B | -$1.10 B(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -$1.01 B(+10.3%) |
| Jun 2018 | - | -$918.17 M(+8.1%) |
| Mar 2018 | - | -$849.43 M(+6.4%) |
| Dec 2017 | -$798.06 M(+65.2%) | -$798.06 M(+12.4%) |
| Sep 2017 | - | -$709.78 M(+12.2%) |
| Jun 2017 | - | -$632.64 M(+15.1%) |
| Mar 2017 | - | -$549.56 M(+13.7%) |
| Dec 2016 | -$483.15 M(+69.7%) | -$483.15 M(+13.2%) |
| Sep 2016 | - | -$426.67 M(+17.3%) |
| Jun 2016 | - | -$363.83 M(+18.2%) |
| Mar 2016 | - | -$307.88 M(+8.1%) |
| Dec 2015 | -$284.68 M(+70.5%) | -$284.68 M(+16.6%) |
| Sep 2015 | - | -$244.06 M(+19.8%) |
| Jun 2015 | - | -$203.80 M(+18.6%) |
| Mar 2015 | - | -$171.91 M(+3.0%) |
| Dec 2014 | -$166.95 M(+47.2%) | -$166.95 M(+19.0%) |
| Sep 2014 | - | -$140.28 M(-2.6%) |
| Jun 2014 | - | -$143.99 M(+14.6%) |
| Mar 2014 | - | -$125.69 M(+10.8%) |
| Dec 2013 | -$113.44 M(+53.2%) | -$113.44 M(+12.3%) |
| Sep 2013 | - | -$101.06 M(+12.4%) |
| Jun 2013 | - | -$89.89 M(+10.6%) |
| Mar 2013 | - | -$81.27 M(+9.8%) |
| Dec 2012 | -$74.04 M(+37.3%) | -$74.04 M |
| Dec 2011 | -$53.94 M | - |
FAQ
- What is Agios Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual retained earnings year-on-year change?
- What is Agios Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly retained earnings year-on-year change?
What is Agios Pharmaceuticals annual retained earnings?
The current annual retained earnings of AGIO is -$148.92 M
What is the all time high annual retained earnings for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual retained earnings is -$53.94 M
What is Agios Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, AGIO annual retained earnings has changed by +$673.73 M (+81.90%)
What is Agios Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of AGIO is -$148.92 M
What is the all time high quarterly retained earnings for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly retained earnings is $30.85 M
What is Agios Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, AGIO quarterly retained earnings has changed by +$673.73 M (+81.90%)